dsbA Antibody

What is DsbA Antibody?

DsbA antibodies are immunoglobulins developed to recognize DsbA, a periplasmic disulfide oxidoreductase essential for catalyzing disulfide bond formation in bacterial proteins. DsbA is conserved across Gram-negative pathogens and is a virulence factor due to its role in folding toxins, adhesins, and biofilm-related proteins . Antibodies against DsbA are primarily used in Western blot (WB), ELISA, and immunohistochemistry (IHC) to study its expression, localization, and interaction with substrates .

Types of DsbA Antibodies

DsbA antibodies vary in clonality, host species, and applications:

Notes:

3.1. Bacterial Pathogenesis

DsbA antibodies have been instrumental in studying virulence mechanisms:

• In Vibrio parahaemolyticus, DsbA antibodies confirmed that DsbA mutants exhibit reduced cytotoxicity and hemolytic activity due to impaired disulfide bonding in toxins like TDH .

• Acinetobacter baumannii DsbA (AbDsbA) antibodies revealed its role in biofilm formation and interaction with elongation factor Tu (EF-Tu), highlighting its potential as an anti-virulence target .

3.2. Protein Folding Studies

• Insulin reduction assays using DsbA antibodies demonstrated that V. parahaemolyticus DsbA has a redox potential of −89 mV, enabling efficient substrate oxidation .

• Structural studies with E. coli DsbA antibodies identified its hydrophobic groove as critical for binding partner oxidase DsbB .

3.3. Diagnostic Development

• Monoclonal antibodies (e.g., 8A10) achieve >95% purity in WB, detecting DsbA at 24 kDa without cross-reactivity .

• Anti-DsbA antibodies are used in affinity columns to purify DsbA-fusion proteins from bacterial lysates .

4.1. DsbA in E. coli

• Function: Essential for disulfide bond formation in periplasmic proteins (e.g., PhoA, OmpA) .

• Redox Properties:

  • Redox potential: −122 mV (CPHC active site) .

  • pK$_a$: 3.4, enabling rapid thiol-disulfide exchange .

Challenges and Future Directions

• Species Specificity: Most antibodies target E. coli DsbA, limiting studies in other pathogens .

• Therapeutic Potential: Inhibitors targeting DsbA’s interaction with DsbB could disrupt virulence in multidrug-resistant bacteria .